Show simple item record

dc.contributor.authorSingh, Baljit
dc.date.accessioned2022-04-21T15:20:41Z
dc.date.available2022-04-21T15:20:41Z
dc.date.issued2022-02
dc.identifier.citationSingh, U., Singh, B., & Bellini, M. I. (2022). Immunosuppressive regimens and outcomes of inflammatory bowel disease patients requiring kidney transplantation. World journal of transplantation, 12(2), 21–23.en_US
dc.identifier.otherhttps://doi.org/10.5500/wjt.v12.i2.21
dc.identifier.urihttp://hdl.handle.net/20.500.12904/15365
dc.description.abstractPatients with inflammatory bowel disease (IBD) can develop extra-renal complications and as a result, suffer from end stage renal failure requiring kidney transplantation (KT). A brief review of available literature revealed that IBD patients undergoing KT have shorter overall survival rates compared to their controls. Literature reporting steroid regimens and survival outcomes specific to IBD and post kidney transplant are scarce and these studies have small sample sizes thus making it difficult to draw accurate conclusions. Further research is required in the form of a randomized controlled study to clarify the effect and mechanism of steroid immunosuppression on the prognosis of renal transplant recipients and explore new treatment schemes.
dc.description.urihttps://www.wjgnet.com/2220-3230/full/v12/i2/21.htmen_US
dc.subjectCrohns diseaseen_US
dc.subjectImmunosuppressionen_US
dc.subjectInflammatory bowel diseaseen_US
dc.subjectKidney failureen_US
dc.subjectKidney transplantationen_US
dc.subjectSteroidsen_US
dc.subjectUlcerative colitisen_US
dc.titleImmunosuppressive regimens and outcomes of inflammatory bowel disease patients requiring kidney transplantationen_US
dc.typeArticleen_US
rioxxterms.funderDefault funderen_US
rioxxterms.identifier.projectDefault projecten_US
rioxxterms.versionNAen_US
rioxxterms.versionofrecordhttps://doi.org/10.5500/wjt.v12.i2.21en_US
rioxxterms.typeJournal Article/Reviewen_US
refterms.panelUnspecifieden_US
html.description.abstractPatients with inflammatory bowel disease (IBD) can develop extra-renal complications and as a result, suffer from end stage renal failure requiring kidney transplantation (KT). A brief review of available literature revealed that IBD patients undergoing KT have shorter overall survival rates compared to their controls. Literature reporting steroid regimens and survival outcomes specific to IBD and post kidney transplant are scarce and these studies have small sample sizes thus making it difficult to draw accurate conclusions. Further research is required in the form of a randomized controlled study to clarify the effect and mechanism of steroid immunosuppression on the prognosis of renal transplant recipients and explore new treatment schemes.en_US
rioxxterms.funder.project94a427429a5bcfef7dd04c33360d80cden_US


This item appears in the following Collection(s)

Show simple item record